Dietary supplement for irritable bowel syndrome with metabolic issues
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether a dietary supplement can help people who have both irritable bowel syndrome (IBS) and signs of metabolic syndrome (like high blood sugar or high blood pressure). It might ease your belly symptoms and improve your overall metabolic health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have belly pain at least once a week for the past 3 months, and it relates to pooping, changes in how often you poop, or changes in how your poop looks.
- You also have at least two signs of metabolic syndrome, such as high blood sugar, a larger waist (or BMI over 30), high blood pressure, low 'good' cholesterol, high triglycerides, or protein in your urine.
- You are not allergic to any of the supplement ingredients.
- You have not been diagnosed with metabolic syndrome before.
- You have never had a stroke or a heart attack.
- You do not currently have mood problems, kidney or intestinal disease, pancreatitis, diabetes, or other hormone-related conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.
This study tests a dietary supplement called Enzymax DuoBiotics to see if it helps ease irritable bowel syndrome (IBS) symptoms like belly pain and irregular bowel habits. If you have IBS and are looking for a non-drug option, this may be a good fit.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
This trial tests whether a low-FODMAP diet (a diet that avoids certain carbohydrates that can cause bloating and gas) can improve gut health in people with Irritable Bowel Syndrome. If you have IBS, this diet might help reduce your symptoms and improve how well your intestines work.
This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.